Transglutaminase 2 as a biomarker of osteoarthritis: An update

Amino Acids

Volumn 44, Issue 1, 2013, Pages 199-207

  Tarantino, Umberto ^a   Ferlosio, Amedeo ^b   Arcuri, Gaetano ^a   Spagnoli, Luigi Giusto ^b   Orlandi, Augusto ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Joint tissue; Osteoarthritis; Transforming growth factor beta; Transglutaminase 2

Indexed keywords

BLOOD CLOTTING FACTOR 13A; COLLAGEN TYPE 10; GLUCOSAMINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 5;

BONE MINERALIZATION; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; HUMAN; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; FEMUR HEAD; HUMANS; KNEE JOINT; OSTEOARTHRITIS; TRANSFORMING GROWTH FACTOR BETA; TRANSGLUTAMINASES;

MUS;

EID: 84871942751     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1181-y     Document Type: Review

References (90)

1. Aeschlimann D, Thomazy V (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41:1-27
2. Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M (1993) Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 120:1461-1470
3. Aeschlimann D, Kaupp O, Paulsson M (1995) Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J Cell Biol 129:881-892
4. Aeschlimann D, Mosher D, Paulsson M (1996) Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin Thromb Hemost 22:437-443
5. Alini M, Kofsky Y, Wu W, Pidoux I, Poole AR (1996) In serum-free culture thyroid hormones can induce full expression of chondrocyte hypertrophy leading to matrix calcification. J Bone Miner Res 11:105-113
6. Attur MG, Patel IR, Patel RN, Abramson SB, Amin AR (1998) Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 110:65-72
7. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, Vanbavel E (2005) Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96:119-126
8. Ballestar E, Abad C, Franco L (1996) Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 271:18817-18824
9. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB, Osteoarthritis Biomarkers Network (2006) Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthr Cartil 14:723-727
10. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, Mukherjee BB (1994) Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem 115:675-682
11. Bini A, Itoh Y, Kudryk BJ, Nagase H (1996) Degradation of crosslinked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Biochemistry 35:13056-13063
12. Blaney Davidson EN, van der Kraan PM, van den Berg WB (2007) TGF-beta and osteoarthritis. Osteoarthr Cartil 15:597-604
13. Borge L, Demignot S, Adolphe M (1996) Type II transglutaminase expression in rabbit articular chondrocytes in culture: relation with cell differentiation, cell growth, cell adhesion and cell apoptosis. Biochim Biophys Acta 1312:117-124
14. Cecil DL, Terkeltaub R (2008) Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J Immunol 180:8378-8385
15. Chen JS, Mehta K (1999) Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 31:817-836
16. Collighan RJ, Griffin M (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36:659-670
17. Cummings M (1996) Apoptosis of epithelial cells in vivo involves tissue transglutaminase upregulation. J Pathol 179:288-293
18. De Laurenzi V, Melino G (2001) Gene disruption of tissue transglutaminase. Mol Cell Biol 21:148-155
19. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R (1995) Toward a molecular understanding of skeletal development. Cell 80:371-378
20. Eyre DR (2004) Collagens and cartilage matrix homeostasis. Clin Orthop Rel Res 427:S118-S122
21. Facchiano A, Facchiano F (2009) Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 36:599-614
22. Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534-539
23. Fésüs L, Szondy Z (2005) Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579:3297-3302
24. Fesus L, Madi A, Balajthy Z, Nemes Z, Szondy Z (1996) Transglutaminase induction by various cell death and apoptosis pathways. Experientia (Basel) 52:942-949
25. Garvican ER, Vaughan-Thomas A, Innes JF, Clegg PD (2010) Biomarkers of cartilage turnover. Part 1: markers of collagen degradation and synthesis. Vet J 185:36-42
26. Gerstenfeld LC, Shapiro FD (1996) Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem 62:1-9
27. Goldenberg DL, Cohen AS (1978) Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) 57:239-252
28. Goldring MB (2000) The role of the chondrocyte in osteoarthritis. Arthr Rheum 43:1916-1926
29. Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230-237
30. Gray ML, Burstein D, Kim YJ, Maroudas A (2008) 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications. J Orthop Res 26:281-291
31. Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5:3071-3077
32. 2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem 280:23675-23683
33. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199-1209
34. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373:793-803
35. Heinkel D, Gohr CM, Uzuki M, Rosenthal AK (2004) Transglutaminase contributes to CPPD crystal formation in osteoarthritis. Front Biosci 19:3257-3261
36. Ientile R, Caccamo D, Griffin M (2007) Tissue transglutaminase and the stress response. Amino Acids 33:385-394
37. Ishikawa K, Masuda I, Ohira T, Yokoyama M (1989) A histological study of calcium pyrophosphate dihydrate crystal-deposition disease. J Bone Jt Surg Am 71:875-886
38. Janiak A, Zemskov EA, Belkin AM (2006) Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 17:1606-1619
39. Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774
40. Johnson KA, Terkeltaub RA (2005) External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 280:15004-15012
41. Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R (2001) Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 159:149-163
42. Johnson KA, van Etten D, Nanda N, Graham RM, Terkeltaub RA (2003) Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J Biol Chem 278:18824-18832
43. Johnson K, Svensson CI, Etten DV, Ghosh SS, Murphy AN, Powell HC, Terkeltaub R (2004) Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs. Arthr Rheum 50:1216-1225
44. Johnson KA, Rose DM, Terkeltaub RA (2008) Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J Cell Sci 121:2256-2264
45. Kaartinen MT, El-Maadawy S, Rasanen NH, McKee MD (2002) Tissue transglutaminase and its substrates in bone. J Bone Miner Res 17:2161-2173
46. Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, Komori T, Sato S, Takeda S, Karsenty G, Nakamura K, Chung UI, Kawaguchi H (2006) Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthr Rheum 54:2462-2470
47. Katoh S, Nakagawa N, Yano Y, Satoh K, Kohno H, Ohkubo Y, Suzuki T, Kitani K (1996) Hepatocyte growth factor induces transglutaminase activity that negatively regulates the growth signal in primary cultured hepatocytes. Exp Cell Res 222:255-261
48. Kim DS, Park KS, Jeong KC, Lee BI, Lee CH, Kim SY (2009) Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition. Cancer Lett 273:243-249
49. Krane SM (2001) Petulant cellular acts: destroying the ECM rather than creating it. J Clin Invest 107:31-32
50. Lohmander LS, Eyre DR (2005) From biomarker to surrogate outcome to osteoarthritis - what are the challenges? J Rheumatol 32:1142-1143
51. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Natl Rev Mol Cell Biol 4:140-156
52. McCarthy GM (1999) Crystal-induced inflammation and cartilage degradation. Curr Rheumatol Rep 1:101-106
53. Merz D, Liu R, Johnson K, Terkeltaub R (2003) IL-8/CXCL8 and growth-related oncogeneα/CXCL1induce chondrocyte hypertrophic differentiation. Immunology 171:4406-4415
54. Mishra S, Murphy LJ (2004) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279:23863-23868
55. Mosher DF, Proctor RA (1980) Binding and factor XIIIa-mediated cross-linking of a 27 kilodalton fragment of fibronectin to Staphylococcus aureus. Science 209:927-929
56. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264:1593-1596
57. Nemes Z Jr, Adány R, Balázs M, Boross P, Fésüs L (1997) Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J Biol Chem 272:20577-20583
58. Nunes I, Gleizes PE, Metz CN, Rifkin DB (1997) Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136:1151-1163
59. Nurminskaya M, Kaartinen MT (2006) Transglutaminases in mineralized tissues. Front Biosci 11:1591-1606
60. Nurminskaya M, Linsenmayer TF (1996) Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Dev Dyn 206:260-271
61. Nurminskaya M, Magee C, Nurminsky D, Linsenmayer TF (1998) Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization. J Cell Biol 142:1135-1144
62. Nurminskaya M, Magee C, Faverman L, Linsenmayer TF (2003) Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev Biol 263:139-152
63. Orlandi A, Oliva F, Taurisano G, Candi E, Di Lascio A, Melino G, Spagnoli LG, Tarantino U (2009) Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids 36:755-763
64. Petersson IF, Jacobsson LT (2002) Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 16:741-760
65. Poole AR (1996) Pathologic manifestations of joint disease in the athletic horse. In: McIllwraith CW, Trotter GW (eds) Joint disease in the horse. WB Saunders Co, Philadelphia, pp 87-104
66. Poole AR (2003) Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis. Rheum Dis Clin North Am 29:803-818
67. Poole AR, Matsui Y, Hinek A, Lee ER (1989) Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec 224:167-179
68. Prince CW, Dickie D, Krumdieck CL (1991) Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun 177:1205-1210
69. Rosenthal AK, Derfus BA, Henry LA (1997) Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthr Rheum 40:966-970
70. Rosenthal AK, Mosesson MW, Gohr CM, Masuda I, Heinkel D, Seibenlist KR (2004) Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis. Thromb Haemost 91:558-568
71. Ryan LM, McCarty DJ (1997) Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman W (ed) Arthritis and allied conditions: a textbook of rheumatology, 13th edn. Williams and Wilkins, Baltimore, pp 2103-2126
72. Sanchez C, Deberg MA, Bellahcène A, Castronovo V, Msika P, Delcour JP, Crielaard JM, Henrotin YE (2008) Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthr Rheum 58:442-455
73. Sarang Z, Tóth B, Balajthy Z, Köröskényi K, Garabuczi E, Fésüs L, Szondy Z (2009) Some lessons from the tissue transglutaminase knockout mouse. Amino Acids 36:625-631
74. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO 3rd, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Reda DJ, Moskowitz RW, Williams HJ, Clegg DO (2008) The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthr Rheum 58:3183-3191
75. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB (2002) Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 169:507-514
76. Soder S, Hakimiyan A, Rueger DC, Kuettner KE, Aigner T, Chubinskaya S (2005) Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity. Arthr Rheum 52:468-478 B.T
77. Summey BT Jr, Graff RD, Lai TS, Greenberg CS, Lee GM (2002) Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res 20:76-82
78. Takeuchi Y, Ohashi H, Birckbichler PJ, Ikejima T (1998) Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity. Z Naturforsch C 53:352-358
79. Tanaka K, Yokosaki Y, Higashikawa F, Saito Y, Eboshida A, Ochi M (2007) The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol 26:409-418
80. Tarantino U, Oliva F, Taurisano G, Orlandi A, Pietroni V, Candi E, Melino G, Maffulli N (2009) FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice. Amino Acids 36:679-684
81. Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M (2008) Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem 283:20937-20947
82. Terkeltaub RA (2002) What does cartilage calcification tell us about osteoarthritis? J Rheumatol 29:411-415
83. Thacher SM (1989) Purification of keratinocyte transglutaminase and its expression during squamous differentiation. J Invest Dermatol 92:578-584
84. Todhunter RJ (1996) Anatomy and physiology of synovial joints. In: McIllwraith CW, Trotter GW (eds) Joint disease in the horse. WB Saunders Co, Philadelphia, pp 1-28
85. Ueki S, Takagi J, Saito Y (1996) Dual functions of transglutaminase in novel cell adhesion. J Cell Sci 109:2727-2735
86. Verderio EA, Griffin TS, Johnson M (2005) Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res 38:89-114
87. Vignon E, Arlot M, Hartmann D, Moyen B, Ville G (1983) Hypertrophic repair of articular cartilage in experimental osteoarthrosis. Ann Rheum Dis 42:82-88
88. von der Mark K, Kirsch T, Nerlich A, Kuss A, Weseloh G, Gluckert K, Stöss H (1992) Type X collagen synthesis in human osteoarthritic cartilage, Indication of chondrocyte hypertrophy. Arthr Rheum 35:806-811
89. Zemmyo M, Meharra EJ, Kühn K, Creighton-Achermann L, Lotz M (2003) Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. Arthr Rheum 48:2873-2880
90. Zhu Y, Tassi L, Lane W, Mendelsohn ME (1994) Specific binding of the transglutaminase, platelet factor XIII, to HSP27. J Biol Chem 269:22379-22384